The Synthesis and Solid State Pharmaceutical Centre (SSPC), a global hub of
pharmaceutical process innovation and advanced manufacturing, leads the way for
next generation drug manufacture. The SSPC is the largest research collaboration in
Ireland, and one of the largest globally, within the pharmaceutical area.
The SSPC is a unique collaboration between 22 industry partners, nine Irish research
performing organisations and 12 international academic collaborators. In total, the
SSPC supports over 250 active members across academia and industry nationally and
internationally. The role of the SSPC is to link experienced scientists and engineers in
academia and the pharmaceutical industry, to address critical scientific and industryfocused
research challenges. Our research programme leads the way for next
generation drug manufacture, and supports 27 world-class principal investigators, 28
postdoctoral researchers and 60 PhD candidates working across 19 research projects.
These span the entire pharmaceutical production chain from synthesis of the
molecule, to the isolation of the material, and the formulation of the medicine. The
aim of the SSPC is to deliver relevant solutions that address the manufacturing needs
of the pharmaceutical companies and, through this, to build a highly innovative
pharmaceutical community in Ireland.
Research areas:
- New frontiers in pharmaceutical synthesis
- Crystal growth and design
- Drug product formulation and manufacture
- Advanced biopharmaceutical technologies
Research performed by:
- University of Limerick
- University College Cork
- University College Dublin
- Trinity College Dublin
- Dublin City University
- NUI Galway
- Athlone Institute of Technology
- Waterford Institute of Technology
- National Institute for Bioprocessing Research and Training